NEW YORK (TheStreet) -- UBS decreased its price target on Bed Bath & Beyond BBBY to $65 and set a "neutral" rating. The firm noted limited upside to revenue catalyst, with operating metrics down due to rising coupon and capex.
The stock was down 0.38% to $60.75 in pre-market trading on Tuesday.
Must Read: Warren Buffett's 25 Favorite Stocks
- The return on equity has improved slightly when compared to the same quarter one year prior. This can be construed as a modest strength in the organization. When compared to other companies in the Specialty Retail industry and the overall market, BED BATH & BEYOND INC's return on equity exceeds that of the industry average and significantly exceeds that of the S&P 500.
- Net operating cash flow has increased to $781.25 million or 33.41% when compared to the same quarter last year. The firm also exceeded the industry average cash flow growth rate of -3.54%.
- BED BATH & BEYOND INC' earnings per share from the most recent quarter came in slightly below the year earlier quarter. This company has reported somewhat volatile earnings recently. But, we feel it is poised for EPS growth in the coming year. During the past fiscal year, BED BATH & BEYOND INC increased its bottom line by earning $4.81 versus $4.58 in the prior year. This year, the market expects an improvement in earnings ($5.05 versus $4.81).
- BBBY's debt-to-equity ratio is very low at 0.03 and is currently below that of the industry average, implying that there has been very successful management of debt levels. Even though the company has a strong debt-to-equity ratio, the quick ratio of 0.47 is very weak and demonstrates a lack of ability to pay short-term obligations.
- You can view the full analysis from the report here: BBBY Ratings Report